By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.

  • Image of Skyrizi medication Image of Skyrizi medication
    • SKYRIZI ON-BODY

    • QTY 2.4
    • 360 MG/2.4
    • WEAR INJCT
    • Near  Hudson

RISANKIZUMAB (RIS an KIZ ue mab) treats autoimmune conditions, such as psoriasis, arthritis, Crohn disease, and ulcerative colitis. It works by slowing down an overactive immune system.  It is a monoclonal antibody.


There is no lifestyle interaction information available for this medication.